• Seeking Alpha

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Seeking Alpha / 10 hours ago 1 Views

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Reborn Coffee and Tori AI Sign MOU to Implement Smart Retail Technology
Next post
SixFour3 Celebrates Major Growth with Richmond Grand Opening and Maryland Expansion

Comments

Just Posted

  • FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®

    3 hours from now

  • Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2025 Fourth Quarter and Year End Earnings Release and Conference Call Webcast

    3 hours from now

  • SmartCentres Real Estate Investment Trust Announces Voting Results from Annual Meeting of Holders of Units and Special Voting Units

    2 hours from now

  • RYVYL Ceases Negotiations to Restructure Pre-funded Asset Sale

    2 hours from now

  • Freehold Royalties Announces Results from Annual Meeting of Shareholders

    1 hour from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1505

Categories

  • Seeking Alpha 1505

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts